Downregulation of reelin predicts poor prognosis for glioma.

Conclusion: RELN may serve as a potential prognostic marker and promising target molecule for new therapy of glioma.
PMID: 32613843 [PubMed - as supplied by publisher]

Source: Future Medicine: Biomarkers in Medicine - July 4, 2020 Category: Internal Medicine Tags: Biomark Med Source Type: research